𝛼SK or Searchbullish
COCP: CDI-988 Data to be Presented at ICAR 2026
On February 19, 2026, Cocrystal Pharma, Inc. (COCP) announced that initial data from the Phase 1b norovirus challenge study of CDI-988 will be...
What is covered in the Full Insight:
- Introduction
- Business Update and CDI-988 Features
- Clinical Trial Results of CDI-988
- Market Need for Norovirus Treatment
- Impact and Military Relevance
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 8-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- COCP: CDI-988 Data to be Presented at ICAR 202624 Feb 2026
x